These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12634013)

  • 1. Rational design and engineering of therapeutic proteins.
    Marshall SA; Lazar GA; Chirino AJ; Desjarlais JR
    Drug Discov Today; 2003 Mar; 8(5):212-21. PubMed ID: 12634013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science.
    Kostarelos K
    Adv Colloid Interface Sci; 2003 Dec; 106():147-68. PubMed ID: 14672846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical structure modifications and nano-technology applications for improving ADME-Tox properties, a review.
    Farouk F; Shamma R
    Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800213. PubMed ID: 30609117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer action means better drug: tuning up protein therapeutics.
    Szlachcic A; Zakrzewska M; Otlewski J
    Biotechnol Adv; 2011; 29(4):436-41. PubMed ID: 21443940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common structural stability properties of 4-helical bundle cytokines: possible physiological and pharmaceutical consequences.
    Ricci MS; Brems DN
    Curr Pharm Des; 2004; 10(31):3901-11. PubMed ID: 15579079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glycosylation on the stability of protein pharmaceuticals.
    Solá RJ; Griebenow K
    J Pharm Sci; 2009 Apr; 98(4):1223-45. PubMed ID: 18661536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead generation--enhancing the success of drug discovery by investing in the hit to lead process.
    Alanine A; Nettekoven M; Roberts E; Thomas AW
    Comb Chem High Throughput Screen; 2003 Feb; 6(1):51-66. PubMed ID: 12570752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing proteins that work using recombinant technologies.
    Graddis TJ; Remmele RL; McGrew JT
    Curr Pharm Biotechnol; 2002 Dec; 3(4):285-97. PubMed ID: 12463413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing drug-likeness--what are we missing?
    Vistoli G; Pedretti A; Testa B
    Drug Discov Today; 2008 Apr; 13(7-8):285-94. PubMed ID: 18405840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug metabolism and pharmacokinetics in support of drug design.
    Tang W; Lu AY
    Curr Pharm Des; 2009; 15(19):2170-83. PubMed ID: 19601821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific polymer modification of therapeutic proteins.
    Kochendoerfer GG
    Curr Opin Chem Biol; 2005 Dec; 9(6):555-60. PubMed ID: 16233987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.
    Izutsu KI
    Adv Exp Med Biol; 2018; 1081():371-383. PubMed ID: 30288720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-Generation Pharmaceutical Proteins-EUFEPS Workshop on Optimizing Biotech Medicines.
    Pasut G; Veronese FM
    IDrugs; 2007 Mar; 10(3):162-4. PubMed ID: 17351866
    [No Abstract]   [Full Text] [Related]  

  • 18. The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance.
    Tóth G; Bowers SG; Truong AP; Probst G
    Curr Pharm Des; 2007; 13(34):3476-93. PubMed ID: 18220785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letters to the editor.
    Buck R; Altan S
    J Biopharm Stat; 2012; 22(1):206-10. PubMed ID: 22204535
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.